GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
GLOBUS MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$75.65−1.06 (-1.38%)
Close on Oct 19, 2026
- Market cap
- $10.39B
- P/E (TTM)
- 19.3
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
88.9%
119M of 134M shares
Institutional holders
597
83 new, 86 sold out
Net institutional buying
18M
In Q2 2026
Insider trades, 12 months
0 buys · 14 sales
Net sold $17.54M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Janus Henderson Group PLC | 7,029,294 | 6.10% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 5,885,560 | 5.22% | 13G (passive) | Mar 31, 2026 |
| Sonali Paul | 22,087,897 | 16.24% | 13G (passive) amendment | Dec 31, 2023 |
| BlackRock, Inc. | 10,487,237 | 9.10% | 13G (passive) amendment | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of GMED | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 10,806,724 | 8.05% | $853.84M | +309,310 | 0.01% |
| Jupiter Topco LLC | 8,200,423 | 6.11% | $647.93M | New | 0.26% |
| Vanguard Capital Management LLC | 5,107,532 | 3.80% | $403.55M | +74,800 | 0.01% |
| Vanguard Portfolio Management LLC | 4,994,385 | 3.72% | $394.61M | +114,926 | 0.02% |
| Invesco Ltd. | 4,309,771 | 3.21% | $340.52M | −6,883 | 0.03% |
| Kayne Anderson Rudnick Investment Management LLC | 4,279,730 | 3.19% | $338.14M | New | 1.05% |
| State Street Corp | 3,714,029 | 2.77% | $293.54M | +123,657 | 0.01% |
| Sculptor Capital LP | 3,000,000 | 2.23% | $237.03M | −58,000 | 1.93% |
| JPMorgan Chase & Co | 2,743,850 | 2.04% | $230.76M | +148,542 | 0.01% |
| Bank Of Montreal /Can/ | 2,425,491 | 1.81% | $191.64M | +118,310 | 0.06% |
| Alliancebernstein L.P. | 2,380,344 | 1.77% | $205.09M | +629,512 | 0.07% |
| Dimensional Fund Advisors LP | 2,369,310 | 1.76% | $187.25M | +599,413 | 0.03% |
| Geode Capital Management, LLC | 2,153,014 | 1.60% | $170.15M | +40,890 | 0.01% |
| Goldman Sachs Group Inc | 1,781,608 | 1.33% | $140.76M | +649,446 | 0.01% |
| Arrowstreet Capital, Limited Partnership | 1,716,621 | 1.28% | $135.63M | +803,716 | 0.06% |
| Boston Trust Walden Corp | 1,573,361 | 1.17% | $124.31M | +318,451 | 0.95% |
| Allspring Global Investments Holdings, LLC | 1,571,681 | 1.17% | $119.38M | +1,143,641 | 0.18% |
| Boston Partners | 1,554,990 | 1.16% | $122.85M | New | 0.11% |
| GW&K Investment Management, LLC | 1,453,206 | 1.08% | $114.82K | −41,517 | 0.90% |
| Geneva Capital Management LLC | 1,417,067 | 1.06% | $111.96M | −343,904 | 2.57% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 597 | 119M | 88.9% | 83 / 252 | 181 / 86 | 29M | 12M |
| Q1 2026 | 607 | 110M | 81.6% | 108 / 231 | 183 / 53 | 22M | 14M |
| Q4 2025 | 563 | 112M | 83.6% | 132 / 150 | 221 / 50 | 20M | 22M |
| Q3 2025 | 490 | 120M | 89.1% | 80 / 173 | 177 / 64 | 22M | 17M |
| Q2 2025 | 481 | 115M | 85.8% | 67 / 195 | 150 / 94 | 19M | 13M |
| Q1 2025 | 513 | 110M | 81.9% | 92 / 204 | 143 / 68 | 14M | 12M |
| Q4 2024 | 500 | 109M | 81.1% | 104 / 168 | 154 / 43 | 14M | 15M |
| Q3 2024 | 449 | 111M | 82.5% | 54 / 147 | 175 / 52 | 16M | 12M |
| Q2 2024 | 450 | 117M | 87.0% | 69 / 136 | 167 / 55 | 12M | 12M |
| Q1 2024 | 438 | 117M | 87.1% | 72 / 143 | 150 / 42 | 16M | 10M |
| Q4 2023 | 408 | 111M | 82.5% | 52 / 134 | 161 / 65 | 17M | 16M |
| Q3 2023 | 431 | 109M | 81.5% | 92 / 210 | 74 / 41 | 36M | 8M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of GMED | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3,877,935 | 2.89% | $306.40M | 0.25% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 3,595,564 | 2.68% | $284.09M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 2,597,815 | 1.93% | $205.25M | 0.11% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund | 2,207,141 | 1.64% | $174.39M | 0.78% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 1,496,500 | 1.11% | $118.24M | 0.25% | Jun 30, 2026 |
| JPMorgan Mid Cap Value Fund | 1,475,978 | 1.10% | $116.62M | 1.04% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 1,299,484 | 0.97% | $102.67M | 0.11% | Jun 30, 2026 |
| Allspring Special Mid Cap Value Fund | 1,234,495 | 0.92% | $97.54M | 0.72% | Jun 30, 2026 |
| Janus Henderson Triton Fund | 1,111,347 | 0.83% | $87.81M | 1.48% | Jun 30, 2026 |
| Disciplined Value Mid Cap Fund | 1,030,725 | 0.77% | $81.44M | 0.35% | Jun 30, 2026 |
| Invesco Small Cap Value Fund | 1,012,359 | 0.75% | $79.76M | 0.72% | Jul 31, 2026 |
| Invesco Value Opportunities Fund | 825,032 | 0.61% | $65.00M | 0.71% | Jul 31, 2026 |
| Janus Henderson Global Life Sciences Fund | 744,421 | 0.55% | $58.82M | 1.01% | Jun 30, 2026 |
| Fullerthaler Behavioral Small-Cap Growth | 738,600 | 0.55% | $58.36M | 0.94% | Jun 30, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 678,028 | 0.51% | $53.57M | 0.47% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Keith W. Pfeil | President, CEO, Director | 5,833 | 0.00% | Jan 23, 2026 |
| David C. Paul | Executive Chairman, Director, 10% owner | 23,087,808 | 17.20% | Jan 23, 2026 |
| Daniel T. Scavilla | President, CEO, Director | 0 | – | Mar 28, 2025 |
| Kelly Huller | EVP, GC, Corporate Secretary | 0 | – | Feb 27, 2026 |
| Kyle Kline | Senior Vice President, CFO | 0 | – | Jan 23, 2026 |
| James R. Tobin | Director | 0 | – | Sep 16, 2026 |
| Stephen T. Zarrilli | Director | 25,000 | 0.02% | Aug 19, 2026 |
| David D. Davidar | Director | 673,642 | 0.50% | Jul 28, 2026 |
| Ann D. Rhoads | Director | 40,384 | 0.03% | Jun 8, 2026 |
| Dan Lemaitre | Director | 1,097 | 0.00% | Jan 23, 2026 |
| Leslie V. Norwalk | Director | 10,419 | 0.01% | Jan 23, 2026 |
| Robert Andrew Douglas | Director | 2,005 | 0.00% | Jan 23, 2026 |
| Dan Wolterman | Director | 24,025 | 0.02% | Jan 23, 2026 |
| John A. DeFord | Director | 15,578 | 0.01% | Jan 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| James R. Tobin Director | Sep 15, 2026 | Sale | −30,000 | $74.58 | $2.24M | 0 |
| James R. Tobin Director | Sep 15, 2026 | Option exercise | +15,000 | $63.68 | $955.20K | 30,000 |
| James R. Tobin Director | Sep 15, 2026 | Option exercise | +15,000 | $53.75 | $806.25K | 15,000 |
| Stephen T. Zarrilli Director | Aug 18, 2026 | Option exercise | +25,000 | $53.27 | $1.33M | 25,000 |
| Stephen T. Zarrilli Director | Aug 18, 2026 | Sale | −25,000 | $87.04 | $2.18M | 0 |
| David D. Davidar Director | Jul 27, 2026 | Gift | −2,500 | – | – | 507,675 |
| David D. Davidar Director | Jun 5, 2026 | Sale | −25,000 | $80.76 | $2.02M | 510,175 |
| David D. Davidar Director | Jun 5, 2026 | Option exercise | +25,000 | $26.27 | $656.75K | 535,175 |
| Ann D. Rhoads Director | Jun 4, 2026 | Option exercise | +25,000 | $26.27 | $656.75K | 40,384 |
| Kelly Huller EVP, GC, Corporate Secretary | Feb 25, 2026 | Sale(10b5-1 plan) | −20,000 | $94.50 | $1.89M | 0 |
| Kelly Huller EVP, GC, Corporate Secretary | Feb 25, 2026 | Option exercise | +20,000 | $43.58 | $871.60K | 20,000 |
| Kelly Huller EVP, GC, Corporate Secretary | Feb 12, 2026 | Sale(10b5-1 plan) | −10,000 | $87.67 | $876.70K | 0 |
| Kelly Huller EVP, GC, Corporate Secretary | Feb 12, 2026 | Option exercise | +10,000 | $45.64 | $456.40K | 10,000 |
| Leslie V. Norwalk Director | Jan 8, 2026 | Sale(10b5-1 plan) | −2,000 | $101.10 | $202.20K | 10,419 |
| Kyle Kline Senior Vice President, CFO | Jan 8, 2026 | Sale(10b5-1 plan) | −3,594 | $101.10 | $363.35K | 0 |
| Kyle Kline Senior Vice President, CFO | Jan 8, 2026 | Option exercise | +3,594 | $51.87 | $186.42K | 3,594 |
| Leslie V. Norwalk Director | Dec 12, 2025 | Sale(10b5-1 plan) | −4,000 | $88.85 | $355.40K | 12,419 |
| David C. Paul Executive Chairman, Director, 10% owner | Dec 8, 2025 | Option exercise | +34,375 | $25.52 | $877.25K | 60,417 |
| Kyle Kline Senior Vice President, CFO | Dec 1, 2025 | Sale(10b5-1 plan) | −18,542 | $90.00 | $1.67M | 0 |
| Kyle Kline Senior Vice President, CFO | Dec 1, 2025 | Option exercise | +4,896 | $63.68 | $311.78K | 18,542 |
| Kyle Kline Senior Vice President, CFO | Dec 1, 2025 | Option exercise | +5,000 | $64.44 | $322.20K | 13,646 |
| Kyle Kline Senior Vice President, CFO | Dec 1, 2025 | Option exercise | +5,000 | $56.43 | $282.15K | 8,646 |
| Kyle Kline Senior Vice President, CFO | Dec 1, 2025 | Option exercise | +3,646 | $53.14 | $193.75K | 3,646 |
| Kelly Huller SVP, GC, Corporate Secretary | Nov 25, 2025 | Option exercise | +7,500 | $25.96 | $194.70K | 7,500 |
| Kelly Huller SVP, GC, Corporate Secretary | Nov 25, 2025 | Sale(10b5-1 plan) | −7,500 | $90.00 | $675.00K | 0 |
| David D. Davidar Director | Nov 12, 2025 | Sale | −25,000 | $86.00 | $2.15M | 516,275 |
| David D. Davidar Director | Nov 12, 2025 | Option exercise | +25,000 | $25.52 | $638.00K | 541,275 |
| Stephen T. Zarrilli Director | Nov 11, 2025 | Sale | −25,000 | $84.29 | $2.11M | 0 |
| Stephen T. Zarrilli Director | Nov 11, 2025 | Option exercise | +25,000 | $44.14 | $1.10M | 25,000 |
| Ann D. Rhoads Director | Nov 10, 2025 | Sale(10b5-1 plan) | −2,000 | $85.00 | $170.00K | 15,384 |
| Ann D. Rhoads Director | Nov 7, 2025 | Sale(10b5-1 plan) | −8,000 | $81.00 | $648.00K | 17,384 |
| Ann D. Rhoads Director | Sep 15, 2025 | Sale(10b5-1 plan) | −10,000 | $58.46 | $584.60K | 25,384 |
| Ann D. Rhoads Director | Feb 28, 2025 | Sale(10b5-1 plan) | −7,500 | $78.68 | $590.10K | 35,384 |
| Keith W. Pfeil COO, CFO | Jan 10, 2025 | Option exercise | +5,833 | $49.65 | $289.61K | 5,833 |
| Keith W. Pfeil COO, CFO | Jan 10, 2025 | Sale(10b5-1 plan) | −12,501 | $88.17 | $1.10M | 1,666 |
| Keith W. Pfeil COO, CFO | Jan 10, 2025 | Sale(10b5-1 plan) | −1,666 | $89.17 | $148.56K | 0 |
| Keith W. Pfeil COO, CFO | Jan 10, 2025 | Option exercise | +8,334 | $53.27 | $443.95K | 14,167 |
| David D. Davidar Director | Jan 2, 2025 | Gift | −6,100 | – | – | 510,175 |
| Kelly Huller SVP, GC, Corporate Secretary | Dec 2, 2024 | Option exercise | +2,500 | $24.21 | $60.53K | 2,500 |
| Kelly Huller SVP, GC, Corporate Secretary | Dec 2, 2024 | Sale(10b5-1 plan) | −2,500 | $87.00 | $217.50K | 0 |
| David D. Davidar Director | Nov 22, 2024 | Sale(10b5-1 plan) | −6,766 | $85.00 | $575.11K | 516,275 |
| David D. Davidar Director | Nov 22, 2024 | Sale(10b5-1 plan) | −6,746 | $85.00 | $573.41K | 165,967 |
| Dan Lemaitre Director | Nov 22, 2024 | Option exercise | +1,097 | $65.05 | $71.36K | 1,097 |
| Dan Lemaitre Director | Nov 22, 2024 | Sale | −1,097 | $85.02 | $93.27K | 0 |
| David D. Davidar Director | Nov 21, 2024 | Sale(10b5-1 plan) | −13,234 | $85.00 | $1.12M | 523,041 |
| David D. Davidar Director | Nov 21, 2024 | Sale(10b5-1 plan) | −13,254 | $85.00 | $1.13M | 172,713 |
| Dan Lemaitre Director | Nov 21, 2024 | Sale | −13,278 | $85.00 | $1.13M | 0 |
| Dan Lemaitre Director | Nov 21, 2024 | Option exercise | +13,278 | $65.05 | $863.73K | 13,278 |
| Daniel T. Scavilla President, CEO, Director | Nov 21, 2024 | Sale(10b5-1 plan) | −130,000 | $85.00 | $11.05M | 0 |
| Daniel T. Scavilla President, CEO, Director | Nov 21, 2024 | Option exercise | +80,000 | $43.58 | $3.49M | 130,000 |
| Daniel T. Scavilla President, CEO, Director | Nov 21, 2024 | Option exercise | +50,000 | $43.77 | $2.19M | 50,000 |
| David C. Paul Executive Chairman, Director, 10% owner | Nov 15, 2024 | Option exercise | +26,042 | $24.10 | $627.61K | 26,042 |
| Daniel T. Scavilla President, CEO, Director | Nov 6, 2024 | Option exercise | +30,000 | $26.27 | $788.10K | 30,000 |
| Daniel T. Scavilla President, CEO, Director | Nov 6, 2024 | Option exercise | +30,000 | $43.77 | $1.31M | 60,000 |
| Daniel T. Scavilla President, CEO, Director | Nov 6, 2024 | Sale(10b5-1 plan) | −60,000 | $80.02 | $4.80M | 0 |
| Kelly Huller SVP, GC, Corporate Secretary | Nov 6, 2024 | Sale(10b5-1 plan) | −2,500 | $80.02 | $200.05K | 2,500 |
| Kelly Huller SVP, GC, Corporate Secretary | Nov 6, 2024 | Option exercise | +5,000 | $24.21 | $121.05K | 5,000 |
| Kelly Huller SVP, GC, Corporate Secretary | Nov 6, 2024 | Sale(10b5-1 plan) | −2,500 | $82.00 | $205.00K | 0 |
| Kelly Huller SVP, GC, Corporate Secretary | Oct 16, 2024 | Sale(10b5-1 plan) | −7,500 | $75.02 | $562.65K | – |
| Kelly Huller SVP, GC, Corporate Secretary | Oct 16, 2024 | Option exercise | +7,500 | $25.80 | $193.50K | 7,500 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| James R. Tobin Director | Sep 15, 2026 | 30,000 | $2.24M | Sep 15, 2026 | Cashless Option Exercise |
| Stephen T. Zarrilli Director | Aug 18, 2026 | 25,000 | $2.18M | Aug 18, 2026 | Cashless Option Exercise |
| David D. Davidar Director | Jun 5, 2026 | 25,000 | $2.03M | Jun 5, 2026 | Cashless Option Exercise |
| John A. DeFord Former Director | Apr 14, 2026 | 30,000 | $2.79M | Apr 14, 2026 | Cashless Stock Option |
| Kelly Huller Officer | Feb 25, 2026 | 20,000 | $1.89M | Feb 25, 2026 | Cashless Stock Option Exercise |
| Kelly Huller Officer | Feb 12, 2026 | 10,000 | $876.00K | Feb 12, 2026 | Cashless Option Exercise |
| Kyle Kline Officer | Jan 8, 2026 | 3,594 | $363.17K | Jan 8, 2026 | CASHLESS OPTION EXERCISE |
| Leslie V. Norwalk Director | Jan 8, 2026 | 2,000 | $202.00K | Jan 8, 2026 | RSU Vesting |
| Leslie V. Norwalk Director | Dec 12, 2025 | 4,000 | $355.00K | Dec 12, 2025 | RSU Vesting |
| Kyle Kline Officer | Dec 1, 2025 | 18,542 | $1.67M | Dec 1, 2025 | Cashless Stock Option Exercise |
| Kelly Huller Officer | Nov 25, 2025 | 7,500 | $675.00K | Nov 25, 2025 | Cashless Stock Option Exercise |
| Stephen T. Zarrilli Director | Nov 12, 2025 | 25,000 | $2.11M | Nov 11, 2025 | Cashless Stock Option Exercise |
| David D. Davidar Director | Nov 12, 2025 | 25,000 | $2.15M | Nov 12, 2025 | Cashless Option Exercise |
| Ann D. Rhoads Director | Nov 10, 2025 | 2,000 | $170.00K | Nov 10, 2025 | Stock option exercise |
| Ann D. Rhoads Director | Nov 7, 2025 | 8,000 | $647.68K | Nov 7, 2025 | Stock Option Exercise |